Is 1-Week Radiotherapy Safe for Breast Cancer?
TOPLINE:At 1 year, 82% of clients with breast cancer who got a 1-week ultrahypofractionated breast radiotherapy program reported no or moderate toxicities. Many clients likewise reported that the decreased treatment time was a significant advantage of the 1-week radiotherapy schedule.APPROACH:In March 2020, throughout the COVID-19 pandemic, global and nationwide standards advised embracing a 1-week ultrahypofractionated radiotherapy schedule for clients with node-negative breast cancer. Consequently, a stage 3 trial showed that a 1-week routine of 26 Gy in 5 portions resulted in comparable breast cancer results compared to a basic reasonably hypofractionated routine.In this research study, scientists wished to evaluate real life toxicities following ultrahypofractionated radiotherapy and ...